SHATTUCK LABS INC (STTK) Fundamental Analysis & Valuation

NASDAQ:STTK • US82024L1035

Current stock price

6.22 USD
+0.12 (+1.97%)
At close:
6.29 USD
+0.07 (+1.13%)
After Hours:

This STTK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. STTK Profitability Analysis

1.1 Basic Checks

  • STTK had negative earnings in the past year.
  • STTK had a negative operating cash flow in the past year.
  • STTK had negative earnings in each of the past 5 years.
  • STTK had a negative operating cash flow in each of the past 5 years.
STTK Yearly Net Income VS EBIT VS OCF VS FCFSTTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • STTK's Return On Assets of -53.62% is in line compared to the rest of the industry. STTK outperforms 45.86% of its industry peers.
  • STTK has a Return On Equity of -59.24%. This is comparable to the rest of the industry: STTK outperforms 58.77% of its industry peers.
Industry RankSector Rank
ROA -53.62%
ROE -59.24%
ROIC N/A
ROA(3y)-63.72%
ROA(5y)-51.17%
ROE(3y)-71.42%
ROE(5y)-57.74%
ROIC(3y)N/A
ROIC(5y)N/A
STTK Yearly ROA, ROE, ROICSTTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • STTK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STTK Yearly Profit, Operating, Gross MarginsSTTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K

8

2. STTK Health Analysis

2.1 Basic Checks

  • STTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STTK has been increased compared to 1 year ago.
  • Compared to 5 years ago, STTK has more shares outstanding
  • There is no outstanding debt for STTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STTK Yearly Shares OutstandingSTTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
STTK Yearly Total Debt VS Total AssetsSTTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • STTK has an Altman-Z score of 23.44. This indicates that STTK is financially healthy and has little risk of bankruptcy at the moment.
  • STTK has a Altman-Z score of 23.44. This is amongst the best in the industry. STTK outperforms 90.75% of its industry peers.
  • There is no outstanding debt for STTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.44
ROIC/WACCN/A
WACC9.28%
STTK Yearly LT Debt VS Equity VS FCFSTTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 11.70 indicates that STTK has no problem at all paying its short term obligations.
  • STTK has a Current ratio of 11.70. This is amongst the best in the industry. STTK outperforms 84.59% of its industry peers.
  • STTK has a Quick Ratio of 11.70. This indicates that STTK is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of STTK (11.70) is better than 84.59% of its industry peers.
Industry RankSector Rank
Current Ratio 11.7
Quick Ratio 11.7
STTK Yearly Current Assets VS Current LiabilitesSTTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1

3. STTK Growth Analysis

3.1 Past

  • STTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.32%, which is quite impressive.
  • Looking at the last year, STTK shows a very negative growth in Revenue. The Revenue has decreased by -82.52% in the last year.
  • STTK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.82% yearly.
EPS 1Y (TTM)48.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.57%
Revenue 1Y (TTM)-82.52%
Revenue growth 3Y15.44%
Revenue growth 5Y-36.82%
Sales Q2Q%N/A

3.2 Future

  • STTK is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.42% yearly.
  • Based on estimates for the next years, STTK will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.
EPS Next Y31.21%
EPS Next 2Y18.13%
EPS Next 3Y7.58%
EPS Next 5Y-1.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STTK Yearly Revenue VS EstimatesSTTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2033 20M 40M 60M 80M
STTK Yearly EPS VS EstimatesSTTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

0

4. STTK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STTK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STTK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STTK Price Earnings VS Forward Price EarningsSTTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STTK Per share dataSTTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.13%
EPS Next 3Y7.58%

0

5. STTK Dividend Analysis

5.1 Amount

  • No dividends for STTK!.
Industry RankSector Rank
Dividend Yield 0%

STTK Fundamentals: All Metrics, Ratios and Statistics

SHATTUCK LABS INC

NASDAQ:STTK (3/20/2026, 8:24:01 PM)

After market: 6.29 +0.07 (+1.13%)

6.22

+0.12 (+1.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-05
Earnings (Next)04-29
Inst Owners63.81%
Inst Owner Change14.86%
Ins Owners1.65%
Ins Owner Change0%
Market Cap445.10M
Revenue(TTM)1.00M
Net Income(TTM)-48.81M
Analysts80
Price Target7.4 (18.97%)
Short Float %3.22%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.8%
Min EPS beat(2)7.68%
Max EPS beat(2)13.92%
EPS beat(4)4
Avg EPS beat(4)7.86%
Min EPS beat(4)3.96%
Max EPS beat(4)13.92%
EPS beat(8)7
Avg EPS beat(8)7.44%
EPS beat(12)10
Avg EPS beat(12)7.91%
EPS beat(16)12
Avg EPS beat(16)5.97%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)81.25%
EPS NQ rev (1m)-6.42%
EPS NQ rev (3m)-6.42%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 445.1
P/FCF N/A
P/OCF N/A
P/B 5.4
P/tB 5.4
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0.01
BVpS1.15
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.62%
ROE -59.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-63.72%
ROA(5y)-51.17%
ROE(3y)-71.42%
ROE(5y)-57.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.93%
Cap/Sales 7.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.7
Quick Ratio 11.7
Altman-Z 23.44
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)4.51%
Cap/Depr(5y)193.27%
Cap/Sales(3y)10.9%
Cap/Sales(5y)369.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.57%
EPS Next Y31.21%
EPS Next 2Y18.13%
EPS Next 3Y7.58%
EPS Next 5Y-1.42%
Revenue 1Y (TTM)-82.52%
Revenue growth 3Y15.44%
Revenue growth 5Y-36.82%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y36.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.4%
EBIT Next 3Y-24.92%
EBIT Next 5YN/A
FCF growth 1Y34.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.1%
OCF growth 3YN/A
OCF growth 5YN/A

SHATTUCK LABS INC / STTK Fundamental Analysis FAQ

What is the fundamental rating for STTK stock?

ChartMill assigns a fundamental rating of 3 / 10 to STTK.


Can you provide the valuation status for SHATTUCK LABS INC?

ChartMill assigns a valuation rating of 0 / 10 to SHATTUCK LABS INC (STTK). This can be considered as Overvalued.


Can you provide the profitability details for SHATTUCK LABS INC?

SHATTUCK LABS INC (STTK) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for STTK stock?

The Earnings per Share (EPS) of SHATTUCK LABS INC (STTK) is expected to grow by 31.21% in the next year.